335 related articles for article (PubMed ID: 25438232)
1. Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS study.
Greve AM; Bang CN; Berg RM; Egstrup K; Rossebø AB; Boman K; Nienaber CA; Ray S; Gohlke-Baerwolf C; Nielsen OW; Okin PM; Devereux RB; Køber L; Wachtell K
Int J Cardiol; 2015 Feb; 180():122-8. PubMed ID: 25438232
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of the electrocardiogram in predicting cardiovascular mortality in asymptomatic adults with aortic stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study).
Greve AM; Dalsgaard M; Bang CN; Egstrup K; Rossebø AB; Boman K; Cramariuc D; Nienaber CA; Ray S; Gohlke-Baerwolf C; Okin PM; Devereux RB; Køber L; Wachtell K
Am J Cardiol; 2014 Sep; 114(5):751-6. PubMed ID: 25048345
[TBL] [Abstract][Full Text] [Related]
3. Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study.
Bang CN; Greve AM; Boman K; Egstrup K; Gohlke-Baerwolf C; Køber L; Nienaber CA; Ray S; Rossebø AB; Wachtell K
Am Heart J; 2012 Apr; 163(4):690-6. PubMed ID: 22520536
[TBL] [Abstract][Full Text] [Related]
4. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.
Rossebø AB; Pedersen TR; Boman K; Brudi P; Chambers JB; Egstrup K; Gerdts E; Gohlke-Bärwolf C; Holme I; Kesäniemi YA; Malbecq W; Nienaber CA; Ray S; Skjaerpe T; Wachtell K; Willenheimer R;
N Engl J Med; 2008 Sep; 359(13):1343-56. PubMed ID: 18765433
[TBL] [Abstract][Full Text] [Related]
5. Stroke in patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
Greve AM; Dalsgaard M; Bang CN; Egstrup K; Ray S; Boman K; Rossebø AB; Gohlke-Baerwolf C; Devereux RB; Køber L; Wachtell K
Stroke; 2014 Jul; 45(7):1939-46. PubMed ID: 24903982
[TBL] [Abstract][Full Text] [Related]
6. Left atrial size and function as predictors of new-onset of atrial fibrillation in patients with asymptomatic aortic stenosis: the simvastatin and ezetimibe in aortic stenosis study.
Bang CN; Dalsgaard M; Greve AM; Køber L; Gohlke-Baerwolf C; Ray S; Rossebø AB; Egstrup K; Wachtell K
Int J Cardiol; 2013 Oct; 168(3):2322-7. PubMed ID: 23416018
[TBL] [Abstract][Full Text] [Related]
7. Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
Greve AM; Gerdts E; Boman K; Gohlke-Baerwolf C; Rossebø AB; Nienaber CA; Ray S; Egstrup K; Pedersen TR; Køber L; Willenheimer R; Wachtell K
Int J Cardiol; 2013 Jun; 166(1):72-6. PubMed ID: 21996417
[TBL] [Abstract][Full Text] [Related]
8. Assessing Optimal Blood Pressure in Patients With Asymptomatic Aortic Valve Stenosis: The Simvastatin Ezetimibe in Aortic Stenosis Study (SEAS).
Nielsen OW; Sajadieh A; Sabbah M; Greve AM; Olsen MH; Boman K; Nienaber CA; Kesäniemi YA; Pedersen TR; Willenheimer R; Wachtell K
Circulation; 2016 Aug; 134(6):455-68. PubMed ID: 27486164
[TBL] [Abstract][Full Text] [Related]
9. Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events.
Rieck ÅE; Cramariuc D; Boman K; Gohlke-Bärwolf C; Staal EM; Lønnebakken MT; Rossebø AB; Gerdts E
Hypertension; 2012 Jul; 60(1):90-7. PubMed ID: 22647889
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
Greve AM; Boman K; Gohlke-Baerwolf C; Kesäniemi YA; Nienaber C; Ray S; Egstrup K; Rossebø AB; Devereux RB; Køber L; Willenheimer R; Wachtell K
Circulation; 2012 Jan; 125(2):346-53. PubMed ID: 22147903
[TBL] [Abstract][Full Text] [Related]
11. Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis.
Gerdts E; Rossebø AB; Pedersen TR; Cioffi G; Lønnebakken MT; Cramariuc D; Rogge BP; Devereux RB
Circ Cardiovasc Imaging; 2015 Nov; 8(11):e003644; discussion e003644. PubMed ID: 26489804
[TBL] [Abstract][Full Text] [Related]
12. Impact of stroke volume on cardiovascular risk during progression of aortic valve stenosis.
Lønnebakken MT; De Simone G; Saeed S; Boman K; Rossebø AB; Bahlmann E; Gohlke-Bärwolf C; Gerdts E
Heart; 2017 Sep; 103(18):1443-1448. PubMed ID: 28455295
[TBL] [Abstract][Full Text] [Related]
13. Incidence of cancer and mortality in patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial.
Green A; Ramey DR; Emneus M; Iachina M; Stavem K; Bolin K; McNally R; Busch-Sørensen M; Willenheimer R; Egstrup K; Kesäniemi YA; Ray S; Basta N; Kent C; Pedersen TR
Am J Cardiol; 2014 Nov; 114(10):1518-22. PubMed ID: 25267716
[TBL] [Abstract][Full Text] [Related]
14. Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study.
Rossebø AB; Pedersen TR; Allen C; Boman K; Chambers J; Egstrup K; Gerdts E; Gohlke-Bärwolf C; Holme I; Kesäniemi VA; Malbecq W; Nienaber C; Ray S; Skjaerpe T; Wachtell K; Willenheimer R
Am J Cardiol; 2007 Apr; 99(7):970-3. PubMed ID: 17398194
[TBL] [Abstract][Full Text] [Related]
15. Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction.
Jander N; Minners J; Holme I; Gerdts E; Boman K; Brudi P; Chambers JB; Egstrup K; Kesäniemi YA; Malbecq W; Nienaber CA; Ray S; Rossebø A; Pedersen TR; Skjærpe T; Willenheimer R; Wachtell K; Neumann FJ; Gohlke-Bärwolf C
Circulation; 2011 Mar; 123(8):887-95. PubMed ID: 21321152
[TBL] [Abstract][Full Text] [Related]
16. Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EF.
Jander N; Hochholzer W; Kaufmann BA; Bahlmann E; Gerdts E; Boman K; Chambers JB; Nienaber CA; Ray S; Rossebo A; Pedersen TR; Wachtell K; Gohlke-Bärwolf C; Neumann FJ; Minners J
Heart; 2014 Dec; 100(24):1946-53. PubMed ID: 25217488
[TBL] [Abstract][Full Text] [Related]
17. Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study).
Bang CN; Greve AM; La Cour M; Boman K; Gohlke-Bärwolf C; Ray S; Pedersen T; Rossebø A; Okin PM; Devereux RB; Wachtell K
Am J Cardiol; 2015 Dec; 116(12):1840-4. PubMed ID: 26602073
[TBL] [Abstract][Full Text] [Related]
18. Observed and predicted reduction of ischemic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis trial.
Holme I; Boman K; Brudi P; Egstrup K; Gohlke-Baerwolf C; Kesäniemi YA; Malbecq W; Rossebø AB; Wachtell K; Willenheimer R; Pedersen TR
Am J Cardiol; 2010 Jun; 105(12):1802-8. PubMed ID: 20538134
[TBL] [Abstract][Full Text] [Related]
19. Global left ventricular load in asymptomatic aortic stenosis: covariates and prognostic implication (the SEAS trial).
Rieck AE; Gerdts E; Lønnebakken MT; Bahlmann E; Cioffi G; Gohlke-Bärwolf C; Ray S; Cramariuc D
Cardiovasc Ultrasound; 2012 Nov; 10():43. PubMed ID: 23126645
[TBL] [Abstract][Full Text] [Related]
20. Relation of Lipid-Lowering Therapy to Need for Aortic Valve Replacement in Patients With Asymptomatic Mild to Moderate Aortic Stenosis.
Greve AM; Bang CN; Boman K; Egstrup K; Kesäniemi YA; Ray S; Pedersen TR; Wachtell K
Am J Cardiol; 2019 Dec; 124(11):1736-1740. PubMed ID: 31586530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
